Management of delayed intrathoracic esophageal perforation with modified intraluminal esophageal stent.
Zhou JH, Gong TQ, Jiang YG, Wang RW, Zhao YP, Tan QY, Ma Z, Lin YD, Deng B.
Dis Esophagus. 2009;22(5):434-8. doi: 10.1111/j.1442-2050.2008.00927.x. Epub 2009 Jan 23.
PMID:19191858
Preoperative Esophageal Stenting and 5-Year Survival in Patients Undergoing Esophagectomy for Esophageal Cancer: a Population-Based Nationwide Study from Finland.
Helminen O, Sihvo E, Helmiö M, Huhta H, Kallio R, Koivukangas V, Kokkola A, Laine S, Lietzen E, Meriläinen S, Pohjanen VM, Rantanen T, Ristimäki A, Räsänen JV, Saarnio J, Toikkanen V, Tyrväinen T, Valtola A, Kauppila JH; FINEGO group.
Risk factors of stent migration in esophageal cancer patients who underwent fully-covered self-expanding metal stents for malignant dysphagia or tracheoesophageal fistula.
Chou IT, Yu FJ, Shih HY, Liu YW, Lee JY, Chou SH, Hsu JS, Chen WC, Wu IC.
J Formos Med Assoc. 2025 May;124(5):432-438. doi: 10.1016/j.jfma.2024.05.014. Epub 2024 May 31.
PMID:38824057
Mitral valved stent implantation.
Lutter G, Quaden R, Iino K, Hagemann A, Renner J, Hümme T, Cremer J, Lozonschi L.
Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis.
Qin J, Zhu HD, Guo JH, Ni CF, Wu P, Xu H, Mao AW, Lu J, Su C, Teng GJ.
Dis Esophagus. 2019 Dec 31;32(12):doz012. doi: 10.1093/dote/doz012.